Trilogy Metals Inc. (AMEX:TMQ) does about 308.47K shares in volume on a normal day but saw 176777 shares change hands in Friday trading. The company now has a market cap of 112.71M USD. Its current market price is $0.58, marking an increase of 0.59% compared to the previous close of $0.57. The 52 week high reached by this stock is $1.55 whilst the lowest price level in 52 weeks is $0.50. The script in recent trading has seen the stock touch a high of $0.58 and a low of $0.56.
Trilogy Metals Inc. (TMQ) has a 20-day trading average at $0.6440 and the current price is -62.71% off the 52-week high compared with 15.31% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6040 and its 200-day simple moving average is $0.6803. If we look at the stock’s price movements over the week, volatility stands at 7.19%, which increases to 7.64% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 40.02 to suggest the stock is neutral.
7 analysts observing the Trilogy Metals Inc. (TMQ) stock have set the 12-month price targets for the company’s shares at between $0.74 and $1.69. The median price target is 55.73% away from the current levels at $1.31.
FactSet Research has provided data showing that 7 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 2 advise that it is a overweight. 2 analysts have rated it as a buy and 3 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.
The current price level is -11.67%, -4.36%, and -15.31% away from its SMA20, SMA50, and SMA200 respectively, with the TMQ price moving above the 50-day SMA on February 17. Trilogy Metals Inc. (TMQ) stock is down -3.70% over the week and -19.64% over the past month. Its price is 5.09% year-to-date and -62.71% over the past year.
The stock last released its quarterly earnings report for quarter ended 8/30/2022, with the company’s earnings per share (EPS) of -$0.07 below consensus estimates by -$0.02. The company’s next earnings report is expected on 04/05/2023, with forecasts estimating quarterly EPS at -$0.01 and -$0.14 for whole year. TMQ’s earnings per share are forecast to grow by 6.70% this year and 71.40% over next year.
Its 12-month price target is $1.31. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $0.74, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $1.69.
Outstanding shares total 145.87M with insiders holding 15.97% of the shares and institutional holders owning 44.24% of the company’s common stock. The company has a return on equity of -15.70%. The beta has a value of 1.21. Price to book ratio is 0.42.
According to a U.S. Securities and Exchange Commission filing, Multipartner SICAV – Konwave Tran has added its position in Trilogy Metals Inc. (TMQ) to 962,824 shares, mirroring a recent increase by 193.46%. Multipartner SICAV – Konwave Tran added 0.63 million shares of Trilogy Metals Inc. common stock bringing its total worth to about $0.62 million at the end of recent close, SEC documents show. Goehring & Rozencwajg Resources F raise their holdings by 8.46% in the company over the course of the most recent quarter. It now holds a 0.44% position in Trilogy Metals Inc. thanks to 0.65 million shares amounting to $0.42 million.
